首页 > 市场调查报告书 > 医疗设备

市场调查报告书

商品编码

1510411

生育治疗市场规模、份额和成长分析：按产品、按程序、按患者类型、按最终用户、按地区 - 行业预测，2024-2031 年

Infertility Treatment Market Size, Share, Growth Analysis, By Product(Equipment, Microscopes ), By Procedure(Assisted Reproductive Technology ), By Patient Type, By End User, By Region - Industry Forecast 2024-2031

出版日期: 2024年07月04日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年不孕症治疗的市场规模预计为32亿美元，预计将从2023年的34亿美元增长到2031年的54.5亿美元，预测期内（2024-2031年）复合年增长率为6.1% 。

由于不孕率上升、孕产妇年龄增长、生活方式的改变以及医疗技术的进步等多种因素，不孕症治疗市场最近经历了显着增长。不孕症影响着世界上很大一部分人口，推动了对有效和创新治疗方案的需求。辅助生殖技术（ART），例如体外受精（IVF）、卵细胞质内单一精虫显微注射术（ICSI）和相关手术，已成为面临不孕症挑战的夫妇的主流选择。这些技术不断改进，从而提高成功率并改善患者的治疗效果。随着这些技术变得更容易获得和负担得起，不孕症治疗市场预计将进一步扩大。除了技术进步外，对第三方生育方法的接受度提高、可支配收入增加、延迟生育的趋势等因素也在影响市场。

市场概况
辅助生殖技术（ART）
- 体外受精 IVF
- 卵细胞质内单一精虫显微注射术
- 代孕
人工授精
- 在子宫内
- 子宫颈内的
- 输卵管内授精
节育手术
- 腹腔镜检查
- 子宫镜检查
- 子宫肌瘤切除术
- 开放性手术
- 输卵管结扎松解术
- 静脉曲张切除术
- 显微外科重组
- 血管造口术
- 输精管睪丸切开术
其他的

生育治疗市场：依患者类型

市场概况
女士
男性

生育治疗市场：依最终用户分类

市场概况
不孕不育诊所
医院
手术中心
冷冻库
研究机构

生育治疗市场：按地区

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
近期市集活动
主要企业市场占有率（2023年）

主要企业简介

Merck KGaA（Germany）
Bayer AG（Germany）
Ferring Pharmaceuticals（Switzerland）
CooperSurgical, Inc.（United States）
Cook Medical（United States）
Vitrolife AB（Sweden）
Irvine Scientific（United States）
Origio（Denmark）
Progyny, Inc.（United States）
OvaScience（United States）
Monash IVF（Australia）
Genea Limited（Australia）
Boston IVF（United States）
Cryo-Save AG（Switzerland）
Invo Bioscience（United States）
Reproductive Medicine Associates of New Jersey（United States）
Virtus Health（Australia）
LifeGlobal Group, LLC（United States）
Andrology Solutions（United States）
ProcreaTec（Spain）

简介目录

Product Code: SQMIG35D2204

Infertility Treatment Market size was valued at USD 3.2 Billion in 2022 and is poised to grow from USD 3.40 Billion in 2023 to USD 5.45 Billion by 2031, at a CAGR of 6.1% during the forecast period (2024-2031).

The infertility treatments market has seen significant growth recently due to various factors including rising infertility rates, increased maternal age, lifestyle changes, and advancements in medical technology. Infertility affects a substantial portion of the global population, driving the demand for effective and innovative treatment options. Assisted reproductive technology (ART), such as in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and related procedures, have become mainstream choices for couples facing infertility challenges. These technologies have undergone continuous improvements, leading to higher success rates and improved patient outcomes. The market for infertility treatments is expected to expand further as these technologies become more accessible and affordable. In addition to technological advancements, the market is influenced by factors like increasing acceptance of third-party reproduction methods, rising disposable incomes, and the trend of delaying parenthood.

Top-down and bottom-up approaches were used to estimate and validate the size of the Infertility Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Infertility Treatment Market Segmental Analysis

The global Infertility Treatment market is segmented based on product, patient type, procedure, end-user, and region. Based on Product, the market is segmented into Microscopes, Media & Consumables, Accessories which are which are further categorized. By Procedure, it is divided into Assisted Reproductive Technology (In Vitro Fertilization [Intracytoplasmic Morphologically Selected Sperm Injection, Gamete Donation], Intracytoplasmic Sperm Injection, Surrogacy), Artificial Insemination (Intrauterine, Intracervical, and Intratubal), Fertility Surgeries (Laparoscopy, Hysteroscopy, Myomectomy, Laparotomy, Tubal Ligation Reversal, Varicocelectomy, Microsurgical Reconstruction [Vasovasostomy, Vasoepididymostomy]), Others. Based on patient type, the market is segmented into Female Infertility Treatment, and Male Infertility Treatment. Based on End-User, it is segmented into Fertility Clinics, Hospitals, Surgical Centers, Research Institutes. Based on region, the market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle East & Africa.

Drivers of the Infertility Treatment Market

The rise in global infertility rates is attributed to factors such as lifestyle changes, delayed parenthood, and environmental influences. This increase in the number of individuals and couples experiencing fertility challenges has led to a heightened demand for infertility treatment options. Additionally, advancements in medical technology, particularly in assisted reproductive technologies such as in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI), have significantly improved success rates, making these treatments more effective and accessible.

Restraints in the Infertility Treatment Market

One of the primary challenges in the market is the high cost associated with advanced infertility treatments like in vitro fertilization (IVF) and genetic screening. The significant financial burden of these procedures creates a substantial barrier to access for many people. Furthermore, ethical concerns related to assisted reproductive technologies, such as issues surrounding embryo manipulation and the ethical implications of surrogacy, introduce complexities that can hinder market growth.

Market Trends of the Infertility Treatment Market

Increasing consumer awareness and greater adoption of straightforward labeling products: There is a rising trend towards precision medicine approaches, particularly in in vitro fertilization (IVF). Genetic testing and screening technologies have become increasingly essential, enabling more targeted and personalized selection of embryos with higher chances of successful implantation, thereby reducing the risk of genetic disorders. Another significant trend involves the increasing acceptance and integration of third-party reproduction methods. Surrogacy, as well as egg or sperm donation, are gaining wider societal acceptance, offering alternative pathways to parenthood for individuals and couples experiencing infertility challenges.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Ecosystem of the Market
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Market Attractive Index
Degree of Competition

Infertility Treatment Market by Product

Market Overview
Equipment
Microscopes
- Imaging Systems
- Sperm Analyzer Systems
- Ovum Aspiration Pumps
- Micromanipulator Systems
- Incubators
- Gas Analysers
- Laser Systems
- Cryosystems
- Sperm Separation Systems
Media & Consumables
Accessories

Infertility Treatment Market by Procedure

Market Overview
Assisted Reproductive Technology
- In Vitro Fertilization IVF
- Intracytoplasmic Sperm Injection
- Surrogacy
Artificial Insemination
- Intrauterine
- Intracervical
- Intratubal Insemination
Fertility Surgeries
- Laparoscopy
- Hysteroscopy
- Myomectomy
- Laparotomy
- Tubal Ligation Reversal
- Varicocelectomy
- Microsurgical Reconstruction
- Vasovasostomy
- Vasoepididymostomy
Others

Infertility Treatment Market by Patient Type

Market Overview
Female Infertility Treatment
Male Infertility Treatment

Infertility Treatment Market by End User

Market Overview
Fertility Clinics
Hospitals
Surgical Centres
Cryobanks
Research Institutes

Infertility Treatment Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ferring Pharmaceuticals (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CooperSurgical, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Medical (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vitrolife AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Irvine Scientific (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Origio (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Progyny, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OvaScience (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Monash IVF (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genea Limited (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston IVF (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cryo-Save AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Invo Bioscience (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Reproductive Medicine Associates of New Jersey (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Virtus Health (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LifeGlobal Group, LLC (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Andrology Solutions (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ProcreaTec (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments